Study of High Risk Non Invasive Prenatal Test Population

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04737070

Enrollment

150

Registered

2021-02-03

Start date

2021-02-01

Completion date

2021-07-01

Last updated

2021-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trisomy 21

Brief summary

The investigator want to study the population of high risk (over 1/50) of Trisomy 21. According to french guidelines, these patients needs to have a invasive test (such as amniocentesis) but some patients prefer to have a Non Invasive Prenatal Test, with a potential lack of information.

Interventions

BIOLOGICALPrenatal test for Trisomy 21 screening

prenatal routine test for Trisomy 21 screening (blood test + nuchal translucency test)

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Prenatal screening of Trisomy 21 \> 1/50 (high risk population)

Exclusion criteria

* No

Design outcomes

Primary

Measure	Time frame
number of genetics anomalies	through study completion, an average of 9 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026